CorFlow Therapeutics Company
CorFlow Therapeutics is a medtech startup that develops proprietary technologies for diagnosis and treatment of microvascular obstructions in heart attack patients. The CorFlow technologies enable interventional cardiologists to diagnose and treat MVO in severe heart attack patients thereby potentially reducing the short- and long-term complication rates in these patients.
Founded Date:
2016-01-01
Employee Number:
11-50
Headquarters:
Baar, Zug, Switzerland, Europe
Industry:
Device Manufacturing & Components
Super Industry:
MedTech & Devices
Phone Number:
+41 41 544 55 55
Investors:
415 Capital, M?rieux Equity Partners, Monte Carlo Capital, Panakes Partners, Wellington Partners
Ipo Status:
private
City:
Baar
Region:
Zug
Country:
Switzerland
Founders:
Jon H. Hoem